Hoffmann, Thomas J. https://orcid.org/0000-0001-6893-4449
Graff, Rebecca E. https://orcid.org/0000-0003-0316-8303
Madduri, Ravi K. https://orcid.org/0000-0003-2130-2887
Rodriguez, Alex A.
Cario, Clinton L.
Feng, Karen https://orcid.org/0000-0001-5763-300X
Jiang, Yu https://orcid.org/0000-0003-2914-8300
Wang, Anqi https://orcid.org/0000-0002-0552-4642
Klein, Robert J. https://orcid.org/0000-0003-3539-5391
Pierce, Brandon L. https://orcid.org/0000-0002-7829-952X
Eggener, Scott
Tong, Lin
Blot, William
Long, Jirong
Goss, Louisa B. https://orcid.org/0009-0005-2936-2405
Darst, Burcu F. https://orcid.org/0000-0002-6205-4632
Rebbeck, Timothy https://orcid.org/0000-0002-4799-1900
Lachance, Joseph https://orcid.org/0000-0002-4650-3741
Andrews, Caroline
Adebiyi, Akindele O. https://orcid.org/0000-0003-1869-7910
Adusei, Ben
Aisuodionoe-Shadrach, Oseremen I.
Fernandez, Pedro W. https://orcid.org/0000-0002-8728-9032
Jalloh, Mohamed https://orcid.org/0000-0002-2190-328X
Janivara, Rohini https://orcid.org/0000-0002-0634-2357
Chen, Wenlong C. https://orcid.org/0000-0002-3248-4906
Mensah, James E. https://orcid.org/0000-0003-4133-1722
Agalliu, Ilir https://orcid.org/0000-0002-6248-5790
Berndt, Sonja I.
Shelley, John P.
Schaffer, Kerry
Machiela, Mitchell J. https://orcid.org/0000-0001-6538-9705
Freedman, Neal D.
Huang, Wen-Yi https://orcid.org/0000-0002-4440-3368
Li, Shengchao A.
Goodman, Phyllis J.
Till, Cathee
Thompson, Ian
Lilja, Hans
Ranatunga, Dilrini K.
Presti, Joseph
Van Den Eeden, Stephen K. https://orcid.org/0000-0002-5599-8387
Chanock, Stephen J. https://orcid.org/0000-0002-2324-3393
Mosley, Jonathan D. https://orcid.org/0000-0001-6421-2887
Conti, David V. https://orcid.org/0000-0002-2941-7833
Haiman, Christopher A.
Justice, Amy C. https://orcid.org/0000-0003-0139-5502
Kachuri, Linda https://orcid.org/0000-0002-3226-4727
Witte, John S. https://orcid.org/0000-0003-0146-1434
Article History
Received: 18 October 2023
Accepted: 20 December 2024
First Online: 10 February 2025
Competing interests
: J.S.W. and C.L.C. are nonemployee co-founders of Avail Bio. H.L. is named on a patent for intact PSA assays and a patent for a statistical method to detect prostate cancer that is licensed to and commercialized by OPKO Health. H.L. receives royalties from sales of the test and has stock in OPKO Health. J.S.W. consults for DLA Piper on subject matter unrelated to this study. R.E.G. consults for Hunton Andrews Kurth on subject matter unrelated to this study. The other authors declare no competing interests.